Humana (NYSE:HUM) PT Raised to $340.00

Humana (NYSE:HUM) had its target price upped by SunTrust Banks to $340.00 in a research report sent to investors on Thursday morning, The Fly reports. The firm currently has a hold rating on the insurance provider’s stock.

Other equities analysts have also issued research reports about the stock. Morgan Stanley reduced their price target on shares of Humana from $331.00 to $315.00 and set an overweight rating for the company in a research report on Friday, July 12th. Barclays reduced their price target on shares of Humana from $351.00 to $327.00 and set an overweight rating for the company in a research report on Wednesday, April 17th. Zacks Investment Research lowered shares of Humana from a hold rating to a sell rating in a research report on Thursday, April 11th. Citigroup reduced their price target on shares of Humana from $362.00 to $302.00 and set a buy rating for the company in a research report on Thursday, May 2nd. Finally, UBS Group assumed coverage on shares of Humana in a research report on Tuesday, April 23rd. They set a neutral rating and a $266.00 price target for the company. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the stock. The stock currently has an average rating of Buy and an average target price of $341.21.

Shares of NYSE HUM traded down $4.26 during trading on Thursday, hitting $293.93. The stock had a trading volume of 1,693,200 shares, compared to its average volume of 1,325,080. Humana has a 12 month low of $225.65 and a 12 month high of $355.88. The company has a quick ratio of 1.65, a current ratio of 1.65 and a debt-to-equity ratio of 0.40. The firm has a market capitalization of $38.42 billion, a P/E ratio of 20.20, a PEG ratio of 1.24 and a beta of 0.87. The company’s fifty day moving average price is $272.19.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, July 31st. The insurance provider reported $6.05 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $5.24 by $0.81. The firm had revenue of $16.25 billion during the quarter, compared to analyst estimates of $15.88 billion. Humana had a net margin of 2.99% and a return on equity of 20.77%. The business’s revenue was up 13.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $3.96 EPS. On average, research analysts predict that Humana will post 17.6 earnings per share for the current year.

Large investors have recently modified their holdings of the business. Pacer Advisors Inc. boosted its position in Humana by 6,493.6% during the first quarter. Pacer Advisors Inc. now owns 12,396 shares of the insurance provider’s stock worth $3,298,000 after purchasing an additional 12,208 shares during the period. World Asset Management Inc boosted its position in Humana by 10.9% during the first quarter. World Asset Management Inc now owns 10,840 shares of the insurance provider’s stock worth $2,883,000 after purchasing an additional 1,067 shares during the period. Cribstone Capital Management LLC bought a new position in Humana during the first quarter worth about $230,000. Jupiter Wealth Management LLC bought a new position in Humana during the first quarter worth about $4,660,000. Finally, Stoneridge Investment Partners LLC boosted its position in Humana by 19.8% during the first quarter. Stoneridge Investment Partners LLC now owns 3,826 shares of the insurance provider’s stock worth $1,018,000 after purchasing an additional 632 shares during the period. Hedge funds and other institutional investors own 92.49% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Recommended Story: Economic Bubble

The Fly

Analyst Recommendations for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.